The NRF2-Kelch-like ECH-Associating protein 1 (Keap1), as well as the NRF2-antioxidant response element (ARE), can counteract the harmful effects of reactive oxidants in cancer cells and restore redox balance to promote cancer adaptation. This evidence concerns the gene KEAP1 and cancer.